Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
NCT07547878 · Not yet recruiting
Last updated 2026-05-28This clinical trial is testing whether starting four recommended treatments at once is more effective at keeping people with chronic kidney disease and type 2 diabetes in the study after 6 months.
What this study is testing ClinicalTrials.gov NCT07547878 ↗
Description as written by the study sponsor.
The goal of this clinical trial is to learn if starting four kidney disease medicines quickly and together (a rapid treatment approach) is safe and works well in people with type 2 diabetes and chronic kidney disease. The main questions it aims to answer are: * Is it safe to start these medicines over a short period of time? * How often do kidney function changes or high potassium levels occur? * Does this approach lower protein in the urine (a sign of kidney damage)? * How many participants are able to stay on all four medicines over 6 months? Researchers will compare this approach to usual care, where medicines are started one at a time over several months. Participants will: Be assigned by chance to either this approach or usual care Start up to four approved kidney medicines over about 8 weeks (rapid treatment approach) or follow standard care Have regular clinic visits and lab tests to check kidney function and potassium levels Be followed for about 6 months
Treatments tested
- Finerenone Drug
10-40mg daily
- Semaglutide Drug
.25-1.0mg 1 time a week
- Lotensin also known as Benazepril Drug
10-40mg daily
- Capoten also known as Capotopril Drug
12.5-50mg 3 times a day
- Enalapril Drug
2.5-10mg daily
- Monopril also known as Fosinopril Drug
10-40mg daily
- Lisinopril Drug
5-20mg daily
- Univasc also known as Moexipril Drug
3.75-15mg daily
- Aceon also known as Perindopril Drug
4-16mg daily
- Accupril also known as Quinapril Drug
10-40mg daily
- Altace also known as Ramipril Drug
1.25-5mg daily
- Mavik also known as Trandolapril Drug
1-4mg daily
- Edarbi also known as Azilsartan Drug
40-80mg daily
- Atacand also known as Candesartan Cilexetil Drug
8-32mg daily
- Avapro also known as Irbesartan Drug
150-300mg daily
- Cozaar also known as Losartan Drug
25-100mg daily
- Benicar also known as Olmesartan Drug
20-40mg daily
- Micardis also known as Telmisartan Drug
20-80mg daily
- Diovan also known as Valsartan Drug
80-320mg daily
- Invokana also known as Canagliflozin Drug
100mg daily
- Farxiga also known as Dapagliflozin Propanediol Drug
10mg daily
- Jardiance also known as Empagliflozin Drug
10mg daily
- Ertugliflozin Drug
5mg daily
- Brenzavvy also known as Bexagliflozin Drug
20mg daily
- Sotagliflozin also known as SAR439954 Drug
200-400mg daily
| Main thing measured | On-study retention rate at 6 months |
|---|---|
| Sponsor | Baylor Research Institute |
| Conditions studied | Chronic Kidney Disease, Type 2 Diabetes |
| GLP-1 drugs | — |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07547878 ↗